Your browser is no longer supported. Please, upgrade your browser.
JAZZ Jazz Pharmaceuticals plc daily Stock Chart
Jazz Pharmaceuticals plc
Index- P/E24.79 EPS (ttm)4.81 Insider Own0.90% Shs Outstand55.96M Perf Week7.64%
Market Cap6.68B Forward P/E7.28 EPS next Y16.39 Insider Trans4.01% Shs Float53.73M Perf Month4.31%
Income280.30M PEG4.37 EPS next Q3.37 Inst Own95.20% Short Float5.19% Perf Quarter4.14%
Sales2.19B P/S3.05 EPS this Y24.50% Inst Trans-3.39% Short Ratio4.24 Perf Half Y-20.14%
Book/sh50.19 P/B2.38 EPS next Y38.19% ROA5.20% Target Price158.67 Perf Year-6.78%
Cash/sh17.54 P/C6.80 EPS next 5Y5.67% ROE9.40% 52W Range86.88 - 154.24 Perf YTD-20.07%
Dividend- P/FCF8.24 EPS past 5Y57.70% ROI12.80% 52W High-22.64% Beta1.22
Dividend %- Quick Ratio3.60 Sales past 5Y13.00% Gross Margin94.40% 52W Low37.34% ATR4.21
Employees1620 Current Ratio3.80 Sales Q/Q5.20% Oper. Margin9.50% RSI (14)62.99 Volatility3.14% 3.58%
OptionableYes Debt/Eq0.57 EPS Q/Q-292.30% Profit Margin12.80% Rel Volume1.57 Prev Close118.79
ShortableYes LT Debt/Eq0.56 EarningsMay 05 AMC Payout0.00% Avg Volume657.59K Price119.32
Recom1.90 SMA206.66% SMA5011.45% SMA200-6.50% Volume1,032,664 Change0.45%
Apr-06-20Initiated Jefferies Buy $149
Mar-12-20Upgrade Bernstein Mkt Perform → Outperform $166
Jan-08-20Initiated Goldman Neutral $153
Aug-21-19Downgrade Piper Jaffray Overweight → Neutral $205 → $142
Jun-11-19Initiated Barclays Overweight $164
Mar-20-19Initiated SunTrust Buy $163
Dec-14-18Initiated Wolfe Research Peer Perform
Nov-08-18Reiterated B. Riley FBR Buy $219 → $190
Aug-08-18Reiterated Stifel Buy $180 → $205
Jul-11-18Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-23-18Reiterated H.C. Wainwright Neutral $150 → $160
Mar-19-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-03-18Initiated Leerink Partners Outperform $180
Dec-05-17Reiterated Mizuho Neutral $144 → $150
Nov-10-17Resumed H.C. Wainwright Neutral $150
Nov-08-17Reiterated RBC Capital Mkts Outperform $210 → $195
Oct-19-17Initiated FBR & Co. Buy $206
Oct-05-17Initiated Morgan Stanley Equal-Weight $155
Sep-28-17Initiated Goldman Neutral $165
Aug-25-17Initiated H.C. Wainwright Neutral $144
May-27-20 04:05PM  Jazz Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences PR Newswire
May-14-20 09:53AM  Jazz Pharmaceuticals to Showcase New Data From its Growing Oncology Portfolio at Virtual ASCO and EHA 2020 Meetings PR Newswire
May-13-20 02:57PM  The 11 Best (And 11 Worst) Stocks of the 11-Year Bull Market Kiplinger
May-11-20 08:30AM  Jazz Pharmaceuticals Announces Appointment Of Kim Sablich As Executive Vice President, General Manager Of North America PR Newswire
08:30AM  Bionical Emas and Jazz Pharmaceuticals Enter into an Agreement for Expanded Access to Lurbinectedin in Relapsed Small Cell Lung Cancer in the United States PR Newswire
May-09-20 08:10AM  Why Jazz Pharmaceuticals' Symphony of Growth Is About to End Motley Fool
May-08-20 01:11AM  Edited Transcript of JAZZ earnings conference call or presentation 5-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-06-20 11:39AM  Jazz Pharma (JAZZ) Misses on Q1 Earnings & Sales, Cuts View Zacks
10:19AM  Jazz Reports Mixed Q1 but Xyrem Growth Stays Strong; Lowering FVE to $130 From Virus Impact to Sales Morningstar
07:04AM  Jazz Pharmaceuticals (JAZZ) Q1 2020 Earnings Call Transcript Motley Fool
07:00AM  Why Jazz Pharmaceuticals Sang Off-Key in Q1 Motley Fool
May-05-20 06:45PM  Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates Zacks
May-04-20 10:57AM  Should You Buy Jazz Pharmaceuticals (JAZZ) Ahead of Earnings? Zacks
May-03-20 07:36AM  2 Cheap Healthcare Stocks to Buy Now Motley Fool
Apr-29-20 04:05PM  Jazz Pharmaceuticals Stops Enrollment in Phase 3 Study Evaluating Defibrotide for the Prevention of Veno-Occlusive Disease PR Newswire
Apr-28-20 12:33PM  Jazz Pharmaceuticals (JAZZ) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
12:10PM  Can Jazz (JAZZ) Keep the Earnings Surprise Streak Alive? Zacks
10:48AM  Can This Small-Cap Biotech Win a $1 Billion Market Opportunity for Narcolepsy? Motley Fool
Apr-21-20 04:05PM  Jazz Pharmaceuticals to Report 2020 First Quarter Financial Results on May 5, 2020 PR Newswire -5.08%
Apr-17-20 02:16PM  Introducing Jazz Pharmaceuticals (NASDAQ:JAZZ), The Stock That Dropped 43% In The Last Five Years Simply Wall St.
Apr-13-20 10:29AM  The other possible COVID drug: How a biotech giant jumped into the coronavirus fray American City Business Journals
Apr-07-20 06:40AM  How 3 Philly-area biopharmaceutical firms are working through coronavirus challenges American City Business Journals
Mar-31-20 04:01PM  Jazz Pharmaceuticals Provides COVID-19 Business Update PR Newswire
Mar-26-20 02:53PM  The Top 10 Biotechnology Companies Investopedia +5.33%
11:30AM  Why Is Jazz (JAZZ) Down 18% Since Last Earnings Report? Zacks
09:59AM  Jazz's (JAZZ) Xyrem Follow-On Candidate NDA Gets FDA Acceptance Zacks
Mar-25-20 04:05PM  Jazz Pharmaceuticals Announces FDA Acceptance of New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy PR Newswire
Mar-23-20 12:48AM  Jazz Pharmaceuticals (JAZZ): Are Hedge Funds Right About This Stock? Insider Monkey -8.73%
Mar-15-20 11:32AM  Bearish Bets: 2 Stocks You Really Should Consider Shorting This Week
Feb-27-20 08:45AM  Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year Simply Wall St.
Feb-26-20 04:46PM  Edited Transcript of JAZZ earnings conference call or presentation 25-Feb-20 9:30pm GMT Thomson Reuters StreetEvents -8.38%
04:05PM  Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences PR Newswire
09:03AM  Jazz Pharma (JAZZ) Surpasses Q4 Earnings & Sales Estimates Zacks
Feb-25-20 06:45PM  Jazz Pharmaceuticals (JAZZ) Q4 Earnings and Revenues Top Estimates Zacks
Feb-21-20 12:13PM  Ronald Muhlenkamp's Firm Buys 3 Stocks in 4th Quarter
09:13AM  What Awaits Jazz Pharmaceuticals (JAZZ) in Q4 Earnings? Zacks
Feb-17-20 02:30AM  PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer PR Newswire
Feb-11-20 04:05PM  Jazz Pharmaceuticals to Report 2019 Fourth Quarter and Full Year Financial Results on February 25, 2020 PR Newswire
11:42AM  Highly Rated Jazz Pharmaceuticals Sees A Hike In Its Composite Rating Investor's Business Daily
Feb-03-20 03:46PM  IBD 50 Stocks To Watch: Top Drugmaker Jazz Pharma Working On New Base Investor's Business Daily
Jan-28-20 02:59AM  Jazz (JAZZ) Submits NDA for Xyrem Follow-On Candidate JZP-258 (Revised) Zacks
Jan-27-20 12:10PM  Why Jazz (JAZZ) Could Beat Earnings Estimates Again Zacks
Jan-23-20 10:42AM  Jazz (JAZZ) Submits NDA for Xyrem Follow-On Candidate JZP-258 Zacks
Jan-22-20 08:00AM  Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy PR Newswire
02:30AM  PharmaMar and Jazz Pharmaceuticals Announce the U.S. License Agreement for Lurbinectedin is Effective with the Expiration of the HSR Waiting Period PR Newswire
Jan-21-20 08:41AM  Jazz's (JAZZ) New Sleep Drug Sunosi Gets Approval in Europe Zacks
Jan-20-20 10:35AM  Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea PR Newswire
Jan-13-20 11:22AM  Jazz Pharmaceuticals Sees Composite Rating Improve To 96 Investor's Business Daily
10:37AM  How Did Jazz Pharmaceuticals (JAZZ) Compare Against Top Hedge Fund Stocks in 2019? Insider Monkey
Jan-10-20 08:15AM  Maintaining $140 FVE for Jazz Following Agreement With PharmaMar for Lurbinectedin in SCLC Morningstar
Jan-06-20 04:05PM  Jazz Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-02-20 10:13AM  Do You Like Jazz Pharmaceuticals plc (NASDAQ:JAZZ) At This P/E Ratio? Simply Wall St.
Jan-01-20 11:40AM  JAZZ vs. ZTS: Which Stock Is the Better Value Option? Zacks
Dec-31-19 11:05AM  Jazz Enrolls First Patient in Phase II/III Leukemia Study Zacks
08:21AM featured highlights include: Lithia Motors, Marathon Petroleum, Meritage Homes, Jazz Pharmaceuticals and Barclays PLC Zacks
08:18AM  7 Impressive Growth Stocks to Buy for 2020 Zacks
Dec-30-19 11:50AM  Are Investors Undervaluing Jazz Pharmaceuticals (JAZZ) Right Now? Zacks
09:27AM  5 High Earnings Yield Stocks for a Standout Portfolio Zacks
08:00AM  Jazz Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 2/3 Study Evaluating JZP-458 for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma PR Newswire
Dec-26-19 07:34AM  Create a Value-Based Portfolio With These 4 Low P/CF Stocks Zacks
Dec-24-19 11:30AM  Is Jazz Pharmaceuticals (JAZZ) Outperforming Other Medical Stocks This Year? Zacks
Dec-23-19 09:15AM  Jazz (JAZZ) Hits 52-Week High, Can the Run Continue? Zacks
09:12AM  5 Low Price-to-Book Value Stocks to Buy as 2020 Nears Zacks
Dec-19-19 08:00AM  PharmaMar and Jazz Pharmaceuticals Sign Exclusive License Agreement for Lurbinectedin in the U.S. PR Newswire
Dec-13-19 11:40AM  JAZZ vs. ZTS: Which Stock Is the Better Value Option? Zacks
09:01AM  Zoetis Surges 45.3% YTD on Strong Portfolio & New Approvals Zacks
Dec-12-19 11:50AM  Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? Zacks
Dec-11-19 09:15AM  Another Small Decline as We Wait on Trade Zacks
06:05AM  6 Low Price-to-Book Value Stocks to Buy in December Zacks
Dec-10-19 10:34AM  Stocks To Watch: Jazz Pharmaceuticals Sees Relative Strength Rating Jump To 83 Investor's Business Daily
09:24AM featured highlights include: Quanta Services, Alexion Pharmaceuticals, Jazz Pharmaceuticals and Zacks
Dec-09-19 06:18AM  Create a Standout Portfolio With These 4 Low P/CF Stocks Zacks
Dec-06-19 11:46AM  Hedge Funds Got Back Into Jazz Pharmaceuticals plc (JAZZ) At The Right Time Insider Monkey
Dec-05-19 11:31AM  Jazz (JAZZ) Up 16.4% Since Last Earnings Report: Can It Continue? Zacks
08:02AM  5 Discounted PEG Stocks for GARP Investors Zacks
Dec-04-19 08:20AM  Axsome Narcolepsy Candidate Meets Phase II Goal, Stock Up Zacks
Dec-03-19 04:13PM  Why This IBD 50 Stock Stumbled After Its Rival Posted A 15% Gain Investor's Business Daily
12:45PM  3 Reasons Growth Investors Will Love Jazz (JAZZ) Zacks
Dec-02-19 09:32AM  Bullish Looking Jazz Pharmaceutical Gets a Boost From a Quant Buy Recommendation
09:17AM featured highlights include: Jazz Pharmaceuticals, Mr. Cooper Group, Sonic Automotive, Hibbett Sports and Jones Lang LaSalle Zacks
08:38AM  Aurinia Pharmaceuticals (AUPH) Catches Eye: Stock Jumps 9.8% Zacks
Nov-29-19 09:39AM  Catalyst Focuses on Firdapse Label Expansion Amid Competition Zacks
07:45AM  Buy These 5 Top-Ranked Stocks With Relative Price Strength Zacks
Nov-27-19 09:30AM  JAZZ vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
Nov-26-19 09:10AM  Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? Zacks
Nov-25-19 05:08PM  Zoetis (ZTS) Acquires ZNLabs to Bolster Diagnostics Portfolio Zacks
08:56AM  Jazz Pharmaceuticals plc (JAZZ) Shares March Higher, Can It Continue? Zacks
Nov-22-19 08:48AM  Tilray (TLRY) Looks Good: Stock Adds 7.2% in Session Zacks
Nov-21-19 03:20PM  Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA Zacks
09:43AM  Edited Transcript of JAZZ earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-19-19 07:50AM  Is Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) CEO Paid At A Competitive Rate? Simply Wall St.
Nov-18-19 05:34PM  Rigel Gets Positive CHMP Review for Thrombocytopenia Drug Zacks
10:17AM  Medtronic (MDT) to Report Q2 Earnings: What's in Store? Zacks
09:02AM  Jazz Pharmaceuticals, Canon, Advanced Energy Industries, Inphi and Skyworks Solutions highlighted as Zacks Bull and Bear of the Day Zacks
09:01AM  Jazz's (JAZZ) Sleep Drug Sunosi Nears Approval in Europe Zacks
07:00AM  Bull of the Day: Jazz Pharma (JAZZ) Zacks
Nov-15-19 10:20AM  Why Jazz (JAZZ) Might be Well Poised for a Surge Zacks
09:08AM  New Strong Buy Stocks for November 15th Zacks
07:04AM  Jazz Pharma's sleep disorder drug gets European panel backing Reuters
06:45AM  Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea PR Newswire
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in adult and pediatric patients with narcolepsy; Sunosi for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease; and Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia. The company also offers JZP-258, an oxybate product candidate, to treat EDS and cataplexy with narcolepsy and idiopathic hypersomnia; JZP-324, a low sodium oxybate formulation with the potential to provide a clinically meaningful option for some narcolepsy patients; JZP-385, a T-type calcium channel modulator, for the treatment of essential tremor; JZP-458, a recombinant Erwinia asparaginase, for use as a component of a multi-agent chemotherapeutic regimen in the treatment of pediatric and adult patients; and lurbinectedin, a product candidate under clinical investigation for the treatment of patients with relapsed small cell lung cancer. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; XL-protein GmbH; and Redx Pharma. The company was founded in 2003 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mulligan SeamusDirectorMay 27Buy111.2635,0003,894,0581,152,788May 27 06:36 PM
Mulligan SeamusDirectorMay 26Buy110.6515,0001,659,7471,117,788May 27 06:36 PM
Carr PatriciaVP, Finance & PAOMar 12Sale102.1760061,3026,500Mar 13 06:48 PM
MILLER MICHAEL PATRICKEVP, US CommercialMar 12Sale102.171,500153,25522,118Mar 13 06:46 PM
Larkin FinbarSVP, Technical OperationsMar 09Sale111.4961568,56613,883Mar 10 06:06 PM
Carr PatriciaVP, Finance & PAOMar 09Sale111.4556863,3037,100Mar 10 06:05 PM
Larkin FinbarSVP, Technical OperationsMar 06Sale119.1529234,79314,498Mar 10 06:06 PM
Carr PatriciaVP, Finance & PAOMar 06Sale119.1723227,6487,668Mar 10 06:05 PM
Carr PatriciaVP, Finance & PAOMar 04Sale118.6725330,0247,900Mar 05 07:42 PM
Larkin FinbarSVP, Technical OperationsMar 03Sale119.7527933,41014,790Mar 05 07:44 PM
Carr PatriciaVP, Finance & PAOMar 03Sale119.7524729,5788,153Mar 05 07:42 PM
COZADD BRUCE CChairman & CEOFeb 24Option Exercise11.486,89579,155305,783Feb 26 05:12 PM
MILLER MICHAEL PATRICKEVP, US CommercialFeb 13Sale142.181,500213,27026,571Feb 14 05:39 PM
COZADD BRUCE CChairman & CEOFeb 03Sale143.831,000143,830298,888Feb 05 04:28 PM
MILLER MICHAEL PATRICKEVP, US CommercialJan 13Sale146.781,500220,17028,071Jan 15 04:11 PM
COZADD BRUCE CChairman & CEOJan 02Sale149.611,250187,010299,888Jan 06 06:34 PM
MILLER MICHAEL PATRICKEVP, US CommercialDec 09Sale149.121,500223,68029,571Dec 10 06:06 PM
Carr PatriciaVP, Finance & PAODec 05Option Exercise123.361,667205,6417,549Dec 09 05:19 PM
Carr PatriciaVP, Finance & PAODec 05Sale148.931,749260,4855,800Dec 09 05:19 PM
O'Keefe Kenneth WDirectorDec 04Sale147.826,750997,7744,445Dec 06 07:11 PM
COZADD BRUCE CChairman & CEODec 02Sale150.0010,7501,612,500301,138Dec 04 05:51 PM
COZADD BRUCE CChairman & CEONov 05Sale130.0050065,000311,855Nov 07 06:53 PM
COZADD BRUCE CChairman & CEOOct 01Sale130.0050065,000312,355Oct 03 05:03 PM
Treacy PaulSVP, Technical OperationsAug 12Sale137.404,371600,58916,418Aug 14 05:33 PM
ENRIGHT PATRICK GDirectorAug 09Sale135.6572698,48117,663Aug 12 05:50 PM
Winningham Rick EDirectorAug 09Sale135.6572698,4824,424Aug 12 05:48 PM
Sohn Catherine A.DirectorAug 09Sale135.6572698,4828,848Aug 12 05:38 PM
Schnee ElmarDirectorAug 09Sale135.65817110,8257,197Aug 12 05:36 PM
RIEDEL NORBERT GDirectorAug 09Sale135.6572698,4827,685Aug 12 05:32 PM
O'Keefe Kenneth WDirectorAug 09Sale135.6572698,4825,644Aug 12 05:29 PM
McSharry Heather AnnDirectorAug 09Sale135.65787106,7568,637Aug 12 05:26 PM
Gray PeterDirectorAug 09Sale135.65787106,7579,315Aug 12 05:23 PM
BERNS PAUL LDirectorAug 09Sale135.6572698,4817,966Aug 12 05:07 PM